Skip to main content
Erschienen in: Molecular Neurodegeneration 1/2013

Open Access 01.09.2013 | Poster presentation

Regulation of Fe65 during neuronal differentiation

verfasst von: Niina Koistinen, Kristin Jacobsen, Kerstin Iverfeldt

Erschienen in: Molecular Neurodegeneration | Sonderheft 1/2013

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Background

Fe65 is a ~97kDa neuronal adaptor protein which has been shown to interact with amyloid-β precursor protein (APP) and its homologues APLP1 and APLP2. Fe65 has the ability to bind to the C-terminal YENPTY motif of APP and is believed to be involved in the regulation of APP processing. APP is a type 1-transmembrane protein which can undergo regulated intramembrane proteolysis (RIP) allowing the release of a secreted ectodomain (sAPP) and a small intracellular domain called AICD. AICD has been suggested to function in regulation of gene expression by the formation of a multimeric complex with Fe65. According to previous studies retinoic acid (RA) can up-regulate the expression of both mRNA and protein levels of APP family members in SH-SY5Y cells. Because Fe65 may be essential in APP-mediated transcriptional regulation, the extent of Fe65 protein expression and its localization were investigated in RA differentiated SH-SY5Y cells. Phosphorylation of APP at specific residues has also shown to affect the processing of APP and its binding to specific adaptor proteins, such as Fe65. To further characterize how phosphorylation affects interactions between Fe65 and APP, Fe65 constructs were designed with a tandem affinity purification-tag (TAP-tag) and several Ser/Thr/ Tyr mutant constructs of myc-tagged APP was generated. APP mutants were coexpressed in SH-SY5Y cells with Fe65-TAP in order to investigate if the mutated phosphorylation sites affect the ability of Fe65 to interact with APP or if the gain/loss of interaction with Fe65 affects the processing of APP.

Materials and methods

Human neuroblastoma SH-SY5Y cells were cultured for 6 days in the absence or presence of 10 µM all-trans RA. Cell- and nuclear lysates were subject to western blot analysis with antibodies against FE65. By recombinant techniques Fe65 was TAP-tagged and cloned into a pcDNA3.1(+) vector as was myc-tagged APP. Mutagenesis of APP was generated by site directed mutagenesis. Protein complexes were recovered from SH-SY5Y cell lysates by affinity purification followed by cleavage of the bound protein complex by TEV-protease. The purified Fe65-TAP protein complexes were analyzed by western blot with antibodies against Fe65 and APP.

Results

The levels of full length FE65 was increased in the presence of RA. In addition, an electrophoretic mobility shift of the full length Fe65 was observed, possibly due to posttranslational modification. Furthermore, a nuclear ~65 kDa fragment was observed. All three members of the APP-family can be pulled-down by Fe65-TAP. Upon co-transfection of Fe65-TAP/APPwt and Fe65-TAP/APP-T668A the increased interaction of Fe65-TAP with APP seems to be blocked by the mutation.

Conclusions

Neuronal differentiation alters levels and processing of Fe65. Furthermore, the increased Fe65-APP interaction seems to be dependent on APP Thr668 phosphorylation.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Metadaten
Titel
Regulation of Fe65 during neuronal differentiation
verfasst von
Niina Koistinen
Kristin Jacobsen
Kerstin Iverfeldt
Publikationsdatum
01.09.2013
Verlag
BioMed Central
Erschienen in
Molecular Neurodegeneration / Ausgabe Sonderheft 1/2013
Elektronische ISSN: 1750-1326
DOI
https://doi.org/10.1186/1750-1326-8-S1-P24

Weitere Artikel der Sonderheft 1/2013

Molecular Neurodegeneration 1/2013 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.